Newstral
Article
Sstarobserver.com.au on 2019-10-01 07:19
GILEAD SCIENCES LAUNCHES HIV GRANT PROGRAM FOR AUSTRALIA
Related news
- DUC Berkeley School of Public Health launches fellowship thanks to grant from Gilead Sciencesdailycal.org
- Md. groups to benefit from Gilead Sciences’ $12.6M grant to improve HIV landscape for Black women, girls thedailyrecord.com
- KHIV-1 Screening Tests Market Research Methods that Will Give You Proven Results | Forecast 2021-2027 | Abbott Healthcare, Alere Inc, Brsitol-Myers Squibb, Abbvie Inc, Gilead Sciences, Janssen Therapeutics, BD Biosciences, Beckman Coulter, PointCare Technologies Inc, and Roche Diagnosticsksusentinel.com
- Coronavirus patients eagerly join Gilead Sciences drug studyNew York Post
- Gilead Sciences Makes Lead Gift for HIV/AIDS Clinic Modernizationatlantadailyworld.com
- MTrump administration sues Gilead Sciences over HIV prevention patentsmarketwatch.com
- Gilead Sciences sued over royalty payments on key HIV drugbizjournals.com
- A Chat With Gilead Sciences Legal Ops Leader Gary Tullyjdsupra.com
- BGilead Sciences Stock Is Moving Back Into Favorbarrons.com
- SAustralia Post launches historic marriage equality stampstarobserver.com.au
- SAustralia Can End HIV Transmission by 2025, Say AIDS Researchersstarobserver.com.au
- Trump administration sues Gilead, maker of HIV-prevention drugsbizjournals.com
- NAustralia Shows Promise for Preventative HIV/AIDS Treatmentsnjitvector.com
- Gilead pays startup $123M to develop longer-lasting HIV pillbizjournals.com
- SPride Foundation Australia launches grant round supporting LGBTI people with a disabilitystarobserver.com.au
- Netflix Australia launchesnews.com.au
- LAntiviral Drugs Treatment Market SWOT Analysis, Key Indicators, Forecast 2028: Abbvie, Inc, Novartis AG, Gilead Sciencesliverpoolstudentmedia.com
- Gilead Sciences, Emory and others launch $100 million initiative to address HIV/AIDS crisis in Southbizjournals.com
- Delay in Filing IDS Reduces Patent Term Adjustment - Gilead Sciences, Inc. v. Leejdsupra.com